Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.901,94
0,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC RespireRx Pharmaceuticals Inc (PK) (RSPI) RespireRx Pharmaceuticals Inc (PK) (RSPI) Notizie

RSPI

RespireRx Pharmaceuticals (PK) (RSPI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:RSPI
DataOraFonteTitoloSimboloCompagnia
02/02/202414:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
17/11/202322:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/11/202322:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
13/06/202322:11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
22/05/202322:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/05/202322:08Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/04/202220:17Edgar (US Regulatory)Annual Report (10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
31/03/202222:11Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/01/202222:32Edgar (US Regulatory)Reflects Information That Constitutes a Substantive Change From or Addition to the Information Set Forth in the Last Offering Circular (253g2)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
01/12/202122:07Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
09/08/202115:16Edgar (US Regulatory)Registration a Offering Under the Securities Act of 1933 (1-a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
19/02/202122:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
30/10/202016:19Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
29/10/202011:07Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
20/10/202022:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/10/202012:48Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
02/10/202021:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
15/09/202022:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
12/08/202019:14Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
04/08/202020:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/04/202022:16Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
24/03/202018:51Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
20/12/201815:32Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
29/06/201822:46Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
08/09/201714:15MarketwiredRespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw ConferenceUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
25/08/201716:54MarketwiredRespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides UpdateUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
14/06/201714:45MarketwiredRespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap ConferenceUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
06/06/201723:00MarketwiredRespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MAUSOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
10/02/201714:30MarketwiredRespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
06/01/201714:15MarketwiredRespireRx Pharmaceuticals Inc. to Present at 9th Annual Biotech Showcase(TM) 2017USOTC:RSPIRespireRx Pharmaceuticals Inc (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:RSPI

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network